Journal of Hematology and Clinical Research

Indexing | Heighten Science Publications Corporation
Submit a Manuscript

Enter your

to find colleagues at
Heighten Science Publications

Contact Information

Submission enquiries:
General enquiries:

Ensuring authors' satisfaction with

  • Friendly and hassle-free publication process
  • Less production time of articles
  • Constructive peer-review
  • Enhancing journal reputation
  • Regular feedback system
  • Quick response to authors' queries


We publish a wide range of article types in the Clinical, Medical, Biology, Engineering, Chemistry and Pharma.

Submit a Manuscript

See guidelines and policies.


Contact Information

Heighten Science Publications Corporation

2504 Stillwater CT, Flower Mound
Texas - 75022, USA
Articles Journals Editors Reviewers
Heighpubs » jhcr » onlineFirst

Online First

  • article icon
    Case Report
    Published: 05/03/2019 | Pages: 3(1): 001-010

    Reversal of pure red cell aplasia by varicella zoster virus infection

    Al-Anazi KA, Kanfar S, Aldayel A, Abduljalil O, Sayyed AH

    Background: Pure red cell aplasia is characterized by anemia, reticulocytopenia and diminished bone marrow erythroid precursors. It has multifactorial etiology and consequently several therapeutic interventions.

    PDF   HTML

  • article icon
    Case Report
    Published: 09/17/2018 | Pages: 2(1): 015-020

    Successful management of disseminated Fusarium infection in a patient with acute myeloid leukemia

    AlShammasi S, AlNujaidi D, Bakhit K, Algarni A, Al-Anazi KA

    Background: Invasive fungal infections cause significant morbidity and mortality in patients with hematologic malignancies and in recipients of hematopoietic stem cell transplantation.

    PDF   HTML

  • article icon
    Research Article
    Published: 01/19/2018 | Pages: 2(1): 006-014

    Evaluation of the effects of Leech Salivary Extract (LSE) on Haematological parameters in Rats

    Babayi H, Praise OO, Ajoke LF, Olayemi IK, Baba E, et al.

    The effects of Leech Salivary Extract (LSE) on some haematological, immunological and organ weight parameters in rats, during a twenty eight days oral administration of 25, 50 and 100 mg/kg body weight doses,
    was investigated. LD50 and sub chronic toxicity was determined using standard methods.

    PDF   HTML

  • article icon
    Research Article
    Published: 01/19/2018 | Pages: 2(1): 001-005

    Status of protection against Hepatitis B infection among healthcare workers (HCW) in a tertiary healthcare center in India: results can’t be ignored!

    Prashant P, Nitin A, Suryasanta D, Kumar D

    Background and Aims: the Aim of the study was to find the level of protection among the healthcare workers (nurses, doctors, housekeeping staff and general duty assistants) by doing Anti-HBsAb titer and vaccinate those who were not properly immunized against HBV infection.

    PDF   HTML

  • article icon
    Case Report
    Published: 09/18/2017 | Pages: 1(1): 019-025

    Preservation of Haemostasis with Anti-thrombotic Serotonin Antagonism

    Mark IM Noble* and Angela J Drake-Holland

    An enquiry into the lack of attention awarded to serotonin antagonism in the treatment of arterial thrombosis revealed that the mode of action of serotonin and its platelet receptor antagonists was an action upon thrombus growth, and not, as with other anti-platelet drugs upon the initiation of thrombosis.

    PDF   HTML

  • article icon
    Case Report
    Published: 09/12/2017 | Pages: 1(1): 014-018

    Cytomegalovirus pneumonia and Cryptogenic organizing pneumonia following pediatric stem cell transplantation for leukemia

    Zühre Kaya*, Tuba Şişmanlar, Ayşe Tana Aslan, Öznur Konuş Boyunağa, Işıl Fidan Balcı, İdil Yenicesu and Ülker Koçak

    Background: Knowledge of pulmonary complications (PCs) in children after hematopoetic stem cell transplantation (allo-HSCT) is limited; most data are from adult studies.

    PDF   HTML

  • article icon
    Published: 03/30/2017 | Pages: 1(1): 011-013

    Neutrophil to Lymphocyte Ratio (NLR) in Peripheral Blood: A Novel and Simple Prognostic Predictor of Non-small Cell Lung Cancer (NSCLC)

    Xiaoli Zhang, Ziyuan Zou, Liyu Fan, Xinjie Xu, Yu Siyuan and Peng Luo*

    Lung cancer is the leading cause of cancer-related deaths worldwide, and almost accounts for 20% of these deaths, however, the cure rate is less than 10% [1]. Non-small cell lung cancer (NSCLC) accounts for approximately 85% of all cases of lung cancer [1], but fewer than 15% of individuals diagnosed with NSCLC can survive for more than 5 years, which poses a great threat to the patient’s life and health [2].

    PDF   HTML

  • article icon
    Review Article
    Published: 01/09/2017 | Pages: 1(1): 001-010

    Primary Cutaneous Lymphomas and Interferon Treatment


    Primary cutaneous lymphomas (PCLs) are the second most common group of extranodal non-Hodgkin lymphomas (NHL) with an estimated annual incidence of 1/100.000. Interferons (IFNs) are used in mono or combination therapy for cutaneous lymphomas especially for cutaneous T-cell lymphomas (CTCL) for years. IFN-α is the most widely-used type for cutaneous lymphomas. IFN-α has been shown to be a highly active agent in CTCL with response rates ranging from 40% to 80%. In this review, the current information about PCLs and IFNs treatment is summarized.

    PDF   HTML